comparemela.com

Latest Breaking News On - Key laboratory of translational medicine - Page 1 : comparemela.com

Simcere agree license deal of $492M USD with Almirall

Almirall granted exclusive rights to commercialise SIM0278 for all indications outside the Greater China region, (Mainland China, Hong Kong, Macau and Taiwan)

Hong kongUnited statesComunidad autonoma de catalunaRenhong tangKarl ziegelbauerInnovative pharmaceutical enterprisesSimcere pharmaceutical groupInnovative drug developmentManufacturing enterprises of chinaSpanish stock exchangeKey laboratory of translational medicineGreater chinaMainland chinaPharmaceutical groupChief scientificPharmaceutical group limited

Tamas Oravecz Ph D named SVP, CSO of the U S of Simcere Pharmaceutical Group

/PRNewswire/ Simcere Pharmaceutical Group announces today the appointment of Tamas Oravecz, Ph.D. as Senior Vice President, Chief Scientific Officer of the.

United statesTamas oraveczSimcere us tamasRenghong tangProgram headSimcere pharmaceutical groupDrug administrationUniversity of szeged hungaryBritish council imperial cancer research fundResearch centerKey laboratory of translational medicineNational institutes of health us foodSwiss society for immunologyFogarty international center national institutes of healthPrnewswire simcere pharmaceutical groupHungarian academy of sciences

Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65 4% of Total Revenue

/PRNewswire/ Simcere Pharmaceutical Group Limited (2096.HK) announced its financial results for the first half of 2022. As of June 30, Simcere recorded.

United statesHong kongPrnewswire simcere pharmaceutical groupHong kong stock exchangeSimcere pharmaceutical groupSimcere pharmaceuticalInnovative drug developmentKey laboratory of translational medicinePharmaceutical group limitedDrug evaluationState key laboratoryTranslational medicinePharmaceutical groupSimcere pharmaceutical group limited

vimarsana © 2020. All Rights Reserved.